Dale I Godfrey Selected Research

Dale I Godfrey Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 01/2002
18	Infections 01/2022 - 09/2005
7	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2002
5	COVID-19 01/2022 - 01/2020
5	Autoimmune Diseases (Autoimmune Disease) 12/2011 - 02/2002
4	Inflammation (Inflammations) 01/2022 - 11/2014
4	Lymphoma (Lymphomas) 09/2013 - 03/2004
3	Malaria 01/2020 - 10/2016
3	Sarcoma (Soft Tissue Sarcoma) 12/2009 - 07/2002
2	Human Influenza (Influenza) 01/2021 - 11/2017
2	Tuberculosis (Tuberculoses) 01/2018 - 07/2013
2	Leukemia 06/2015 - 11/2005
2	Melanoma (Melanoma, Malignant) 10/2013 - 11/2005
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2011 - 09/2008
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2009 - 11/2005
2	B-Cell Lymphoma (Lymphoma, B Cell) 02/2009 - 03/2004
2	Hypersensitivity (Allergy) 03/2007 - 04/2003
1	Noncommunicable Diseases 01/2019
1	Polyps 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Multiple Myeloma 01/2016
1	Lymphopenia (Lymphocytopenia) 01/2016
1	HIV Infections (HIV Infection) 02/2015
1	Asthma (Bronchial Asthma) 10/2013
1	Eczema 09/2013
1	Bacterial Infections (Bacterial Infection) 09/2013
1	Liver Diseases (Liver Disease) 12/2011
1	Crohn Disease (Crohn's Disease) 12/2011
1	Experimental Melanoma 12/2009
1	Carcinoma (Carcinomatosis) 12/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2008
1	Persistent Infection 02/2008

Drug/Important Bio-Agent (IBA)

14	CytokinesIBA 01/2022 - 02/2002
13	AntigensIBA 01/2022 - 03/2010
9	alpha-galactosylceramideIBA 09/2008 - 02/2002
6	PerforinIBA 01/2018 - 01/2002
6	Interleukin-12 (IL 12)IBA 02/2006 - 02/2002
5	VaccinesIBA 12/2021 - 10/2016
5	interleukin-21 (interleukin 21)IBA 10/2013 - 06/2005
4	LipidsIBA 01/2017 - 03/2010
3	Interleukin-18 (Interleukin 18)IBA 01/2021 - 02/2002
3	AntibodiesIBA 01/2020 - 12/2011
3	GlycolipidsIBA 01/2020 - 10/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 07/2002
3	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2019 - 12/2015
3	Granzymes (Granzyme)IBA 11/2018 - 06/2004
3	MethylcholanthreneIBA 12/2009 - 07/2002
3	LigandsIBA 12/2009 - 02/2002
3	Interleukin-4 (Interleukin 4)IBA 02/2008 - 02/2002
2	AutoantigensIBA 01/2022 - 02/2002
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2018
2	InterferonsIBA 01/2021 - 10/2013
2	InterleukinsIBA 01/2019 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2019
2	Galactosylceramides (Galactocerebrosides)IBA 01/2018 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2009 - 11/2005
2	Interferon-gamma (Interferon, gamma)IBA 02/2002 - 01/2002
1	ChemokinesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Disinfectants (Biocides)IBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	SuspensionsIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	RezafunginIBA 01/2020
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020
1	EpitopesIBA 01/2020
1	Toll-Like Receptor AgonistsIBA 12/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	ChromatinIBA 01/2019
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2019
1	sulfoglycolipidsIBA 01/2018
1	Antiparasitic Agents (Antiparasitics)IBA 01/2018
1	EstersIBA 01/2018
1	safingol (sphinganine)IBA 01/2018
1	SugarsIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Protein Subunit VaccinesIBA 11/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	pyrimidineIBA 12/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2014
1	GlucocorticoidsIBA 11/2014
1	IntegrinsIBA 09/2013
1	Complement Factor B (Factor B)IBA 09/2013
1	Immunoglobulin E (IgE)IBA 09/2013
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 09/2013
1	VitaminsIBA 11/2012
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 12/2011

Therapy/Procedure

7	Immunotherapy 01/2021 - 04/2002
4	Therapeutics 11/2021 - 10/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Transplantation 04/2009